Quotient buys Edinburgh research facility
Quotient Bioresearch, a provider of drug development services, has acquired an Edinburgh-based clinical research facility from Charles River Laboratories, a global research model and preclinical, clinical and support service specialist. The terms of the deal have not been disclosed.
News